Skip to main content

Instadose Pharma Corp. (OTC: INSD) Investor Files Securities Class Action Lawsuit 12/30/2021

  • If you purchased a significant amount of shares of Instadose Pharma Corp. (OTC: INSD) between December 8, 2020 and November 24, 2021, and / or if you purchased any OTC: INSD shares prior to December 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: February 28, 2022. OTC: INSD investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 25, 2022 - The court clerk made an entry of default on the docket as to both defendants.  August 24, 2022 - A request for entry of default against the defendants for failure to appear or respond in a timely manner to the complaint was made.  December 30, 2021 - An investor in shares of Instadose Pharma Corp. (OTC: INSD) filed a lawsuit in the U.S. District Court for the Eastern...

You must register (for free) or login to view the entire case.